These studies quantified total Akt-mediated phosphorylation of TBC1D4 using an antibody recognising the phosphorylated Akt consensus motif [23], or an antibody recognising phosphorylated TBC1D4 T642 [16,24,28,29,57]
Inoue A, Robinson FS, Minelli R, Tomihara H, Rizi BS, Rose JL, Kodama T, Srinivasan S, Harris AL, Zuniga AM, Mullinax RA, Ma X, Seth S, Daniele JR, Peoples MD, Loponte S, Akdemir KC, Khor TO, Feng N, Roszik J, Sobieski MM, Brunell D, Stephan C, Giuliani V, Deem AK, Shingu T, Deribe YL, Menter DG, Heffernan TP, Viale A, Bristow CA, Kopetz S , Draetta GF, Genovese G, Carugo A
Want a schedule built around a daily dose
The addition of B12 or other ingredients, alternative delivery methods like ODTs, and patient-specific dosing adjustments all serve as bases for continued compounding under Section 503A